Voyageur Pharmaceuticals Ltd. is a listed company. Filings by its managers are published through SEDI. Over the twelve months to 18 October 2026, 16 filings were filed, from 5 insiders.
No open-market purchase or sale appears among the filings, only grants, plan transactions and other operations. Compensation-driven entries like these are tracked, but they say little about how insiders judge the share price.
For context, the typical company on the same exchange (median of 2,130 companies) published 12 filings over the same period, against 16 filings here.
Over the last twelve months, not one insider purchase of Voyageur Pharmaceuticals Ltd. stock was filed. Between a trade and the moment it shows up on SEDI, the median delay is 4 days. Until a filing is published, the market cannot know about the trade.
Every figure here comes from the filings published by SEDI and describes the past, not future prices; it is not investment advice.
This score ranks the purchase within its own market. A position size is suggested only on the venues of the backtested strategy universe; elsewhere, signals stay on watch. Not investment advice.
FY ended November 2025 · cache
16 of 16 declarations
Voyageur Pharmaceuticals Ltd. is a Canadian pharmaceutical company focused on developing health products. It is listed on the Toronto Stock Exchange (XTSE).